Literature DB >> 9843486

Structure of a trimeric domain of the MHC class II-associated chaperonin and targeting protein Ii.

A Jasanoff1, G Wagner, D C Wiley.   

Abstract

The invariant chain (Ii) plays a critical role in MHC class II antigen processing by stabilizing peptide-free class II alphabeta heterodimers in a nonameric (alphabetaIi)3 complex soon after their synthesis and directing transport of the complex from the endoplasmic reticulum to compartments where peptide loading of class II takes place. Loading progresses following Ii proteolysis and via an intermediate complex of MHC class II with an Ii-derived peptide, CLIP. CLIP is substituted by exogenous peptidic fragments in an exchange reaction catalyzed by HLA-DM. The CLIP region of Ii, roughly residues 81-104, is one of two segments shown to interact with class II HLA-DR molecules. The other segment, Ii 118-216, is C-terminal to CLIP, mediates trimerization of the ectodomain of Ii and interferes with DM/class II binding. Here we report the three-dimensional structure of this trimeric domain, determined by nuclear magnetic resonance (NMR) studies of a 27 kDa trimer of human Ii 118-192. The cylindrical shape of the molecule and the mapping of conserved residues delimit surfaces which may be important for interactions between Ii and class II molecules.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843486      PMCID: PMC1171028          DOI: 10.1093/emboj/17.23.6812

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  19 in total

1.  Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins.

Authors:  D R Karp; R N Jenkins; E O Long
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

2.  Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.

Authors:  A Nicholls; K A Sharp; B Honig
Journal:  Proteins       Date:  1991

3.  Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain.

Authors:  P A Roche; M S Marks; P Cresswell
Journal:  Nature       Date:  1991-12-05       Impact factor: 49.962

4.  The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides.

Authors:  I M Freisewinkel; K Schenck; N Koch
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

5.  A calculation strategy for the structure determination of symmetric dimers by 1H NMR.

Authors:  M Nilges
Journal:  Proteins       Date:  1993-11

6.  Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens.

Authors:  C E Machamer; P Cresswell
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

7.  Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1.

Authors:  J Kim; R G Urban; J L Strominger; D C Wiley
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

8.  An asymmetric deuterium labeling strategy to identify interprotomer and intraprotomer NOEs in oligomeric proteins.

Authors:  A Jasanoff
Journal:  J Biomol NMR       Date:  1998-08       Impact factor: 2.835

9.  The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy.

Authors:  P Romagnoli; R N Germain
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

10.  Mapping functional regions in the lumenal domain of the class II-associated invariant chain.

Authors:  M J Bijlmakers; P Benaroch; H L Ploegh
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

View more
  25 in total

1.  Clathrin self-assembly involves coordinated weak interactions favorable for cellular regulation.

Authors:  Diane E Wakeham; Chih-Ying Chen; Barrie Greene; Peter K Hwang; Frances M Brodsky
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

2.  HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis.

Authors:  Roberto Meza-Romero; Gil Benedek; Xiaolin Yu; Jeffery L Mooney; Rony Dahan; Nerri Duvshani; Richard Bucala; Halina Offner; Yoram Reiter; Gregory G Burrows; Arthur A Vandenbark
Journal:  J Immunol       Date:  2014-03-28       Impact factor: 5.422

Review 3.  Ancient features of the MHC class II presentation pathway, and a model for the possible origin of MHC molecules.

Authors:  Johannes M Dijkstra; Takuya Yamaguchi
Journal:  Immunogenetics       Date:  2018-10-30       Impact factor: 2.846

4.  Modeling of both shared and distinct interactions between MIF and its homologue D-DT with their common receptor CD74.

Authors:  Roberto Meza-Romero; Gil Benedek; Kelley Jordan; Lin Leng; Georgios Pantouris; Elias Lolis; Richard Bucala; Arthur A Vandenbark
Journal:  Cytokine       Date:  2016-08-27       Impact factor: 3.861

Review 5.  MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.

Authors:  Pathricia V Tilstam; Dake Qi; Lin Leng; Lawrence Young; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2017-07       Impact factor: 6.902

6.  Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling.

Authors:  Julie M Kneller; Thomas Ehlen; Jasenka P Matisic; Dianne Miller; Dirk Van Niekerk; Wan L Lam; Marco Marra; Rebecca Richards-Kortum; Michelle Follen; Calum Macaulay; Steven J M Jones
Journal:  Biomark Insights       Date:  2007-12-11

7.  Surface properties of Helicobacter pylori urease complex are essential for persistence.

Authors:  Tobias D Schoep; Alma Fulurija; Fayth Good; Wei Lu; Robyn P Himbeck; Carola Schwan; Sung Sook Choi; Douglas E Berg; Peer R E Mittl; Mohammed Benghezal; Barry J Marshall
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

8.  Crystal structure of a macrophage migration inhibitory factor from Giardia lamblia.

Authors:  Garry W Buchko; Jan Abendroth; Howard Robinson; Yanfeng Zhang; Stephen N Hewitt; Thomas E Edwards; Wesley C Van Voorhis; Peter J Myler
Journal:  J Struct Funct Genomics       Date:  2013-05-25

9.  An Analysis of MIF Structural Features that Control Functional Activation of CD74.

Authors:  Georgios Pantouris; Mansoor Ali Syed; Chengpeng Fan; Deepa Rajasekaran; Thomas Yoonsang Cho; Eric M Rosenberg; Richard Bucala; Vineet Bhandari; Elias J Lolis
Journal:  Chem Biol       Date:  2015-09-10

10.  The crystal structures of macrophage migration inhibitory factor from Plasmodium falciparum and Plasmodium berghei.

Authors:  Sarah E Dobson; Kevin D Augustijn; James A Brannigan; Claudia Schnick; Chris J Janse; Eleanor J Dodson; Andrew P Waters; Anthony J Wilkinson
Journal:  Protein Sci       Date:  2009-12       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.